NCT03105336 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 124
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 152
- units
- Participants
- groups
- description
- Participants with relapsed or refractory (r/r) B-cell indolent non-Hodgkin lymphoma (iNHL) subtype of follicular lymphoma (FL) received the following treatment during the study: * A conditioning chemotherapy regimen of fludarabine 30 mg/m\^2/day intravenously (IV) and cyclophosphamide 500 mg/m\^2/day IV for 3 days (Day -5 to Day -3). * A single IV infusion at a target dose of 2×10\^6 anti-cluster of differentiation 19 (CD19) chimeric antigen receptor (CAR) transduced autologous T cells/kg on Day 0.
- id
- BG000
- title
- Axicabtagene Ciloleucel (Follicular Lymphoma)
- description
- Participants with r/r B-cell iNHL subtype of marginal zone lymphoma (MZL) received the following treatment during the study: * A conditioning chemotherapy regimen of fludarabine 30 mg/m\^2/day IV and cyclophosphamide 500 mg/m\^2/day IV for 3 days (Day -5 to Day -3). * A single IV infusion at a target dose of 2×10\^6 anti-CD19 CAR transduced autologous T cells/kg on Day 0.
- id
- BG001
- title
- Axicabtagene Ciloleucel (Marginal Zone Lymphoma)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 86
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 101
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 51
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.9
- value
- 59
- group Id
- BG001
- spread
- 9.6
- value
- 63
- group Id
- BG002
- spread
- 10.0
- value
- 60.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 66
- title
- Female
- measurements
- group Id
- BG000
- value
- 73
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 86
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 118
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 142
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 115
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 140
- title
- White
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- title
- Other or More Than One Race
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- Asian
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 114
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 142
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 10
- title
- France
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- The Safety Analysis Set was defined as all participants treated with any dose of study drug.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 124
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 152
- units
- Participants
- groups
- description
- Participants with relapsed or refractory (r/r) B-cell indolent non-Hodgkin lymphoma (iNHL) subtype of follicular lymphoma (FL) received the following treatment during the study: * A conditioning chemotherapy regimen of fludarabine 30 mg/m\^2/day intravenously (IV) and cyclophosphamide 500 mg/m\^2/day IV for 3 days (Day -5 to Day -3). * A single IV infusion at a target dose of 2×10\^6 anti-cluster of differentiation 19 (CD19) chimeric antigen receptor (CAR) transduced autologous T cells/kg on Day 0.
- id
- BG000
- title
- Axicabtagene Ciloleucel (Follicular Lymphoma)
- description
- Participants with r/r B-cell iNHL subtype of marginal zone lymphoma (MZL) received the following treatment during the study: * A conditioning chemotherapy regimen of fludarabine 30 mg/m\^2/day IV and cyclophosphamide 500 mg/m\^2/day IV for 3 days (Day -5 to Day -3). * A single IV infusion at a target dose of 2×10\^6 anti-CD19 CAR transduced autologous T cells/kg on Day 0.
- id
- BG001
- title
- Axicabtagene Ciloleucel (Marginal Zone Lymphoma)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 86
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 101
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 51
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.9
- value
- 59
- group Id
- BG001
- spread
- 9.6
- value
- 63
- group Id
- BG002
- spread
- 10.0
- value
- 60.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 66
- title
- Female
- measurements
- group Id
- BG000
- value
- 73
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 86
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 118
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 142
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 115
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 140
- title
- White
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- title
- Other or More Than One Race
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- Asian
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 114
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 142
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 10
- title
- France
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- The Safety Analysis Set was defined as all participants treated with any dose of study drug.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle